Gregory Brandt, MD
Professor of Clinical Pediatrics - Pediatric Hematology-Oncology, Pediatric Hematology/Oncology
Pediatrics
About me
Gregory Brandt, MD, is a professor of clinical pediatrics at SIU School of Medicine, specializing in pediatric hematology/oncology. He completed a fellowship in Pediatric Hematology/Oncology/Bone Marrow Transplant at Children’s Hospital Medical Center in Cincinnati, Ohio, and a pediatric residency at St. Louis University/Cardinal Glennon Children’s Hospital in St. Louis, Missouri. Board certified in pediatric hematology/oncology, Brandt is a member of the Children’s Oncology Group and serves as SIU’s principle investigator for research studies.
Gender
Male
Education & training
Positions
Pediatric Hematology Oncologist
Board Certifications
Pediatric Hematology Oncology
Medical School
St. Louis University, School of Medicine, St. Louis, MO
Residency
St. Louis University School of Medicine, St. Louis, MO - Pediatrics
Fellowship
Children's Hospital Medical Center, Cincinnati, OH - Hematology, Oncology, and Bone Marrow Transplant
Featured Publications
[1]
Singh N.
Brandt G.
Torky A.
Ganta A.
Rebound Hypercalcemia in a 14-Year-Old After Denosumab Therapy for Giant Cell Granuloma of the Mandible.
2025 ;12(4):300-303.
PMID: 41467132
PMID: 41467132
[2]
Bielack SS.
Smeland S.
Whelan JS.
Marina N.
Jovic G.
Hook JM.
Krailo MD.
Gebhardt M.
Pápai Z.
Meyer J.
Nadel H.
Randall RL.
Deffenbaugh C.
Nagarajan R.
Brennan B.
Letson GD.
Teot LA.
Goorin A.
Baumhoer D.
Kager L.
Werner M.
Lau CC.
Sundby Hall K.
Gelderblom H.
Meyers P.
Gorlick R.
Windhager R.
Helmke K.
Eriksson M.
Hoogerbrugge PM.
Schomberg P.
Tunn PU.
Kühne T.
Jürgens H.
van den Berg H.
Böhling T.
Picton S.
Renard M.
Reichardt P.
Gerss J.
Butterfass-Bahloul T.
Morris C.
Hogendoorn PC.
Seddon B.
Calaminus G.
Michelagnoli M.
Dhooge C.
Sydes MR.
Bernstein M.
.
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
2015 Jul;33(20):2279-87.
PMID: 26033801
PMID: 26033801
Grants
•Grant: Principal Investigator, Children’s Oncology Group, Ongoing.
Related articles
A year after leukemia diagnosis, clinical trial brings hope
When their 4-year-old son was stricken with leukemia, Chad and Regan Hoesman turned to the children's cancer specialists at SIU Medicine and hoped for the best. A year into his treatment, their little boy received a big gift.